09:00 EDT Landos Biopharma Inc trading resumes
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LABP:
- AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases
- Landos Biopharma Provides Business Update and Reports Fourth Quarter and Full Year 2023 Results
- Landos Biopharma reports Q4 EPS (99c) vs ($1.30) last year
- Landos Biopharma, Inc. (LABP) Q4 Earnings Cheat Sheet
Questions or Comments about the article? Write to editor@tipranks.com